FDA approves new weight loss drug Zepbound – CBS News Watch CBS News The Food and Drug Administration has approved the diabetes drug Mounjaro, which will be marketed as a weight loss drug under the name Zepbound. Be the first to know Get browser notifications for breaking news, live events, and exclusive reporting. Not Now Turn On